Medicine traceability has become a critical priority in global healthcare due to the rising prevalence of counterfeit drugs, cold-chain failures, regulatory non-compliance, and patient safety risks. Traditional, centralized traceability systems—characterized by fragmented databases, manual documentation, and limited transparency—have proven inadequate in addressing the complexities of modern pharmaceutical supply chains. This whitepaper explores how the integration of blockchain and Internet of Things (IoT) technologies establishes a secure, decentralized, and real-time traceability framework. By combining immutable digital ledgers with continuous environmental monitoring, blockchain–IoT architectures enhance transparency, strengthen regulatory oversight, reduce fraud, and safeguard medicine integrity across the entire product lifecycle—from manufacturing to patient consumption.
Key Highlights
- Cold-chain temperature excursions linked to global losses up to USD 35 billion annually.
- WHO estimates at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified.
- ~48% improvement in traceability effectiveness reported in blockchain-integrated IoT systems.
- Smart contracts automate compliance, alerts, invoicing, and recalls.
About The Author
Jason Goya Tiffer
Jason brings more than 20+ years of experience to HBGTM Insights, where he drives global sales and leads strategic initiatives. He specializes in business development, account management, and revenue growth across diverse industries. Jason identifies high-potential markets, drives client-focused strategies, and partners closely with marketing, research, and product teams to deliver integrated solutions. His expertise in market analytics and competitive intelligence ensures new growth opportunities and enhanced client engagement worldwide.
Know More